cilostazol has been researched along with Ambulation Disorders, Neurologic in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cilostazol treatment improved BBB permeability and reduced gait disturbance, visual impairment and microglial activation in optic tract following BCCAO in vivo." | 1.43 | Cilostazol reduces blood brain barrier dysfunction, white matter lesion formation and motor deficits following chronic cerebral hypoperfusion. ( Cadonic, R; Edrissi, H; Hakim, AM; Schock, SC; Thompson, CS, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edrissi, H | 1 |
| Schock, SC | 1 |
| Cadonic, R | 1 |
| Hakim, AM | 1 |
| Thompson, CS | 1 |
| Yentes, JM | 1 |
| Huisinga, JM | 1 |
| Myers, SA | 1 |
| Pipinos, II | 1 |
| Johanning, JM | 1 |
| Stergiou, N | 1 |
1 trial available for cilostazol and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Pharmacological treatment of intermittent claudication does not have a significant effect on gait impairments during claudication pain.
Topics: Aged; Analgesics; Cilostazol; Gait; Gait Disorders, Neurologic; Humans; Intermittent Claudication; M | 2012 |
1 other study available for cilostazol and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Cilostazol reduces blood brain barrier dysfunction, white matter lesion formation and motor deficits following chronic cerebral hypoperfusion.
Topics: Animals; Blood-Brain Barrier; Cell Survival; Cerebral Small Vessel Diseases; Cilostazol; Disease Mod | 2016 |